Department of Medicine, University of Helsinki
Helsinki, FI-00290, Finland
NCT Number: NCT01913171
o determine effects of hula-hooping on android obesity, metabolic parameters and adipose tissue (AT) gene expression.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
Helsinki, FI-00290, Finland
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 6weeks
The primary objective was to evaluate the change in the % fat in the android region as measured by DEXA during 6 weeks of HULA as compared to WALK
Time frame: 6weeks
The secondary objectives included the comparison of differences in waist circumference (cm), relative and absolute trunk and limb muscle mass as measured by DEXA (% and kg), fasting plasma glucose (mmol/l), fasting serum insulin (mU/l), liver enzymes (U/l), fasting plasma LDL and HDL cholesterol and triglycerides (mmol/l). Gene expression was analyzed in adipose tissue biopsies collected before and after each exercise intervention.
Time frame: 6weeks
To determine the effects of HULA compared to WALK on adipose tissue inflammation, a needle aspiration biopsy of abdominal s.c. adipose tissue was taken under local anesthesia with lidocaine before and after each exercise intervention. The adipose tissue sample was immediately frozen in liquid nitrogen and then stored at -80°C until analysis. Total RNA from s.c. AT was isolated.Relative quantification for the genes of interest (see list below) was carried out using normalization to the 36B4 and β-actin mRNA values.
ABCA1 Adiponectin ANGPTL8 CHOP CD4 CD8 CD68 ETFDH FOXP3 GLUT4 MCP-1 MRC-1 PGC-1α VEGF-A β-actin
University of Helsinki
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07645105
Abdominal Obesity-Metabolic Syndrome, Abdominal obesity metabolic syndrome
Miasteczko Śląskie, Silesian Voivodeship, Poland
View Trial DetailsNCT06208163
Abdominal Obesity, Body Weight
Marietta, Georgia, United States
View Trial DetailsNCT05882149
Abdominal Obesity, Body Weight
Reus, Tarragona, Spain
View Trial DetailsNCT07486557
Body Weight, Central Obesity
Beijing, Beijing Municipality, China
View Trial Details